Credit: NCI-CONNECT Staff
Studying tumor tissue and clinical data across our national network of institutions will help researchers advance their knowledge of rare brain and spine tumors faster.
NCI-CONNECT is launching a study across its network of clinical collaborators to better understand rare brain and spine tumors. The study collects tumor tissue and comprehensive clinical data from deceased patients with rare brain and spine tumors and people that were pregnant at diagnosis or became pregnant after diagnosis of a primary brain tumor.
“The data are out there waiting to be analyzed and understood. The more data we collect, the better we can design clinical trials and study therapeutic options that improve the outcomes of patients,” says Marta Penas-Prado, M.D., principal investigator of the study and an associate research physician in the Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH.
Date Time
Share
Treatments for brain tumors are falling short. Here’s what’s being done to change that
The chance of a person developing a malignant brain tumor in his or her lifetime is less than 1%, but for the people who do develop these tumors, treatment options are limited, and advancements are needed to help improve their outcomes and survival.
Each year, the organization Head for the Cure hosts 5K run/walk events across the country to raise hope, awareness and funding for brain cancer research and to celebrate and remember those who have been affected by the disease. This year, a portion of the proceeds raised during the Charleston 5K event, which will be held virtually on Feb. 27, will go directly to MUSC Hollings Cancer Center to help researchers understand brain cancer better in hopes of developing better treatments.